References
- Ross D S. Subclinical hypothyroidism. Werner and Ingbars' The Thyroid 6th edn., LE Braverman, RD Vitiger. JB Lippincot, Philadelphia 1991; 1256–62
- Kabadi U M. ‘Subclinical hypothyroidism’; natural course of the syndrome during a prolonged follow-up study. Arch Intern Med 1993; 153: 957–61
- Tunbridge W M, Evered D C, Hall R, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol 1977; 7: 481–93
- Tunbridge W M, Brewis M, French J M, et al. Natural history of autoimmune thyroiditis. Br Med J (Clin Res) 1981; 282: 258–62
- Helfand M, Crapo L M. Screening for thyroid disease. Ann Intern Med 1990; 112: 840–9
- Cooper D S, Halpern R, Wood L C, et al. L-thyroxine therapy in subclinical hypothyroidism. A double-blind placebo-controlled trial. Ann Intern Med 1984; 101: 18–24
- Ridgway E C, Cooper D S, Walker H, et al. Peripheral responses to thyroid hormone before and after L-thyroxine therapy in patients with subclinical hypothyroidism. J Clin Endocrinol Metab 1981; 53: 1238–42
- Arem R, Patsch W. Lipoprotein and apolipo-protein levels in subclinical hypothyroidism. Effect of levothyroxine therapy. Arch Intern Med 1990; 150: 2097–100
- Neer R M. Osteoporosis. Endocrinology 3rd edn., LJ DeGroot. WB Saunders, Philadelphia 1995; 1245
- Paul T L, Kerrigan J, Kelly A M, et al. Long-term L-thyroxine therapy is associated with decreased hip bone density in premenopausal women. JAMA 1988; 259: 3137–41
- Ross D S, Neer R M, Ridgway E C, et al. Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary–thyroid axis with L-thyroxine. Am J Med, 82: 1167–70
- Schneider M D, Barrett-Connor E L, Morton D J. Thyroid hormone use and bone mineral density in elderly women. JAMA 1994; 271: 1245–9
- Lindsay R, Hart D M, Forrest C, et al. Prevention of spinal osteoporosis in oophorectomised women. Lancet 1980; ii: 1151–4
- Ettinger B, Genant H K, Cann C E. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med 1985; 102: 319–24
- Eastell R. Treatment of postmenopausal osteoporosis. N Engl J Med 1998; 338: 736–46
- Heaney R P. Estrogen–calcium interactions in the postmenopause: a quantitative description. Bone Mineral 1990; 11: 67–84
- Baran D T, Braverman L E. Thyroid hormone and bone mass. J Clin Endocrinol Metab 1991; 72: 1182–3
- Franklyn J A, Betteridge J, Daykin J, et al. Long-term thyroxine treatment and bone mineral density. Lancet 1992; 340: 9–13
- Ross D S. Bone density is not reduced during the short-term administration of levothyroxine to postmenopausal women with subclinical hypothyroidism: a randomized, prospective study. Am J Med 1993; 95: 385–8
- Fujiyama K, Kiriyama T, Ito M, et al. Suppressive doses of thyroxine do not accelerate age-related bone loss in late postmenopausal women. Thyroid 1995; 5: 13–17
- Arata N, Momotani N, Maruyama H, et al. Bone mineral density after surgical treatment for Graves' disease. Thyroid 1997; 7: 547–54